Mesirow Financial Investment Management Inc. acquired a new position in Senseonics Holdings Inc (NYSEAMERICAN:SENS) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 63,151 shares of the company’s stock, valued at approximately $301,000.
Other hedge funds have also bought and sold shares of the company. Gilder Gagnon Howe & Co. LLC acquired a new stake in shares of Senseonics in the 2nd quarter valued at about $74,936,000. Hilltop Holdings Inc. acquired a new position in Senseonics during the 2nd quarter valued at about $394,000. GSA Capital Partners LLP acquired a new position in Senseonics during the 2nd quarter valued at about $268,000. Bank of Montreal Can acquired a new position in Senseonics during the 2nd quarter valued at about $1,030,000. Finally, Broadview Advisors LLC acquired a new position in Senseonics during the 2nd quarter valued at about $2,774,000. 30.66% of the stock is owned by hedge funds and other institutional investors.
A number of equities analysts have issued reports on SENS shares. Craig Hallum started coverage on Senseonics in a research note on Monday, June 11th. They set a “buy” rating and a $7.00 price target for the company. Dougherty & Co started coverage on Senseonics in a research note on Friday, August 24th. They set a “buy” rating and a $6.00 price target for the company. BTIG Research reiterated a “buy” rating and set a $6.00 price target on shares of Senseonics in a research note on Thursday, August 9th. Finally, Raymond James lifted their price target on Senseonics from $4.00 to $6.00 and gave the company an “outperform” rating in a research note on Friday, June 22nd. Six equities research analysts have rated the stock with a buy rating, Senseonics presently has a consensus rating of “Buy” and an average target price of $6.00.
Senseonics (NYSEAMERICAN:SENS) last released its quarterly earnings results on Wednesday, August 8th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.09). Senseonics had a negative net margin of 828.76% and a negative return on equity of 406.72%. The company had revenue of $3.62 million for the quarter, compared to analyst estimates of $3.87 million. During the same quarter last year, the firm posted ($0.12) EPS. Senseonics’s revenue for the quarter was up 345.1% on a year-over-year basis. On average, equities research analysts anticipate that Senseonics Holdings Inc will post -0.54 earnings per share for the current fiscal year.
Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.
Featured Story: Stock Symbols, CUSIP and Other Stock Identifiers
Want to see what other hedge funds are holding SENS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Senseonics Holdings Inc (NYSEAMERICAN:SENS).
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.